Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Colla corii asini, commonly known as Ejiao or donkey-hide gelatin, is a traditional Chinese medicine (TCM) produced from the skin of the donkey (*Equus asinus* L.) through a meticulous process of decoction and concentration. It is primarily composed of collagen, amino acids, dermatan sulfate, and trace elements. Historically utilized for its hematopoietic and "blood-tonifying" properties, recent clinical research has focused on its efficacy in treating anemia, particularly in pregnant women with thalassemia, and its potential protective effects in chronic obstructive pulmonary disease (COPD). The drug's pharmacological profile involves the modulation of the ER/AKT/NF-κB signaling pathway, where it acts to upregulate estrogen receptors (ERα and ERβ) and inhibit the pro-inflammatory AKT/NF-κB axis, thereby reducing the production of inflammatory mediators like TNF-α and IL-1β while enhancing anti-inflammatory markers such as IL-10.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on colla corii asini.